India Glycols Ltd. Shareholders Meeting on March 24, 2026, for Scheme of Arrangement
India Glycols Limited will hold an Equity Shareholders meeting on March 24, 2026, via Video Conference. The meeting will consider and approve a Scheme of Arrangement involving the demerger of entities. Remote e-voting is open from March 20-23, 2026. The cut-off date for voting eligibility is March 17, 2026.
The announcement concerns a significant corporate restructuring (scheme of arrangement/demerger) which, if approved, can have a substantial impact on the company's structure, operations, and shareholder value. Therefore, the impact is considered medium.
The announcement is a procedural notice regarding a shareholder meeting for a scheme of arrangement, which is a routine corporate action. It does not contain information that would immediately suggest a positive or negative financial or operational impact.
India Glycols Limited (IGL) has announced a meeting of its Equity Shareholders, convened by the Hon'ble National Company Law Tribunal (NCLT), Allahabad Bench, Prayagraj. This meeting is scheduled to be held on Tuesday, March 24, 2026, at 11:00 A.M. (IST) through Video Conferencing (VC).
The primary purpose of this meeting is to consider and approve a Scheme of Arrangement amongst India Glycols Limited (Demerged Company), Ennature Biopharma Limited (Resulting Company 1), and IGL Spirits Limited (Resulting Company 2), along with their respective shareholders.
Shareholders will have the facility to cast their vote through electronic means. Remote e-voting will commence on Friday, March 20, 2026, at 9:00 A.M. (IST) and conclude on Monday, March 23, 2026, at 5:00 P.M. (IST). E-voting will also be available during the meeting and for 15 minutes thereafter. The cut-off date to determine entitlement for voting and attending the meeting is Tuesday, March 17, 2026.
Detailed instructions for remote e-voting, joining the meeting via VC, and other related procedures are provided in the Notice of Meeting and accompanying documents, which are also available on the company's website.
What to do with a filing like this
India Glycols Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Glycols Limited. Read the original for the full detail.